首页> 美国卫生研究院文献>Marine Drugs >The Application of Seaweed Polysaccharides and Their Derived Products with Potential for the Treatment of Alzheimer’s Disease
【2h】

The Application of Seaweed Polysaccharides and Their Derived Products with Potential for the Treatment of Alzheimer’s Disease

机译:海藻多糖的应用及其衍生产品具有治疗阿尔茨海默病的潜力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Neurodegenerative diseases are among the most widespread diseases affecting humans, and the number of patients is only rising. Seaweed polysaccharide extracts show significant neuroprotective and reparative activities. Seaweed polysaccharides might provide the next big breakthrough in neurodegenerative disease treatment. This paper reviews the applications of seaweed polysaccharides as potential treatments of neurodegenerative diseases. The particular focus is on fucoidan, ulvan, and their derivatives as potential agents to treat Alzheimer’s disease. This review provides a critical update on the progress in this important research area.
机译:神经退行性疾病是影响人类的最普遍的疾病之一,患者的数量只是上升。海藻多糖提取物显示出显着的神经保护和修复活动。海藻多糖可能提供神经变性疾病治疗中的下一个重大突破。本文综述了海藻多糖作为神经变性疾病的潜在治疗的应用。特定的重点是在岩藻浮梨,乌尔(Ulvan及其衍生物上作为治疗阿尔茨海默病的潜在药剂。该审查提供了关于这一重要研究区域进展的关键更新。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号